<DOC>
	<DOCNO>NCT01233544</DOCNO>
	<brief_summary>This randomized clinical phase III trial test efficacy radiofrequency ablation ( RFA ) stereotactic body radiotherapy ( SBRT ) treatment colorectal carcinoma liver metastasis . Primary end point local progression free survival .</brief_summary>
	<brief_title>Radiofrequency Ablation Versus Stereotactic Radiotherapy Colorectal Liver Metastases</brief_title>
	<detailed_description>Patients 1-4 inoperable colorectal liver metastasis , 4 cm diameter randomize either RFA SBRT . Primary end point local progression free survival . Chemotherapy allow study treatment .</detailed_description>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Neoplasms , Second Primary</mesh_term>
	<mesh_term>Liver Neoplasms</mesh_term>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<criteria>Adenocarcinoma colon rectum Liver metastases Inoperable ( technical medical ) 14 metastasis Maximum 40 mm diameter Suitable therapy , RFA SBRT Uncontrolled extrahepatic disease uncontrolled primary cancer Liver cirrhosis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Colorectal carcinoma</keyword>
	<keyword>Liver metastasis</keyword>
	<keyword>Stereotactic body radiation therapy</keyword>
	<keyword>Radiofrequency ablation</keyword>
</DOC>